Alembic Pharmaceuticals Limited (BOM:533573)

Alembic Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	173,084	193,575	97,564	145,771	189,674	100,715
Market Cap Growth	40.41%	98.41%	-33.07%	-23.15%	88.33%	-0.66%
Enterprise Value	182,453	200,785	104,548	151,109	193,139	115,147
Last Close Price	881.45	971.38	485.05	714.04	916.17	506.57
PE Ratio	28.62	31.43	28.53	27.98	16.54	12.15
PS Ratio	2.70	3.11	1.73	2.75	3.52	2.19
PB Ratio	3.54	4.02	2.23	2.78	3.74	3.16
P/TBV Ratio	3.54	4.02	2.23	2.87	4.00	3.45
P/FCF Ratio	-	40.69	34.78	115.04	23.60	-
P/OCF Ratio	-	24.10	13.48	26.39	12.96	22.42
EV/Sales Ratio	2.84	3.22	1.85	2.85	3.58	2.50
EV/EBITDA Ratio	18.48	21.97	15.02	17.60	13.17	9.18
EV/EBIT Ratio	25.39	30.39	23.88	25.72	14.89	10.36
EV/FCF Ratio	-	42.21	37.27	119.26	24.03	-
Debt / Equity Ratio	0.22	0.11	0.17	0.14	0.12	0.57
Debt / EBITDA Ratio	1.08	0.55	1.01	0.82	0.39	1.44
Debt / FCF Ratio	-	1.08	2.57	5.66	0.73	-
Asset Turnover	-	0.99	0.85	0.77	0.85	0.86
Inventory Turnover	-	1.15	1.15	0.97	1.00	1.01
Quick Ratio	-	0.82	0.74	0.52	0.51	0.55
Current Ratio	-	2.12	1.78	1.67	2.07	1.41
Return on Equity (ROE)	-	13.40%	7.12%	10.11%	27.77%	27.10%
Return on Assets (ROA)	-	6.54%	4.11%	5.31%	12.77%	12.90%
Return on Capital (ROIC)	7.94%	7.92%	4.95%	6.33%	15.19%	15.67%
Return on Capital Employed (ROCE)	-	13.20%	9.60%	10.90%	23.90%	26.20%
Earnings Yield	3.49%	3.18%	3.50%	3.57%	6.04%	8.23%
FCF Yield	-	2.46%	2.88%	0.87%	4.24%	-2.84%
Dividend Yield	1.29%	1.13%	1.65%	1.40%	1.53%	1.38%
Payout Ratio	-	25.54%	57.48%	52.83%	-	28.43%
Buyback Yield / Dilution	-0.15%	-	-	-1.46%	-2.77%	-
Total Shareholder Return	1.15%	1.13%	1.65%	-0.06%	-1.24%	1.38%

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.